Mangrove Partners’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Mangrove Partners’s Portfolio IMVTW Stock Details IMVTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100,000	Closed	-$240K	–	92
2020 Q1	$240K	Hold	100,000	–	–	0.03%	51
2019 Q4	$200K	Buy	+100,000	New	+$203K	0.03%	51

Mangrove Partners's IMVTW Position: Q2 2020 in Review

Mangrove Partners sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 100,000 shares — an estimated $240K sold.

Mangrove Partners first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $240K in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

Mangrove Partners reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
Mangrove Partners sold 100,000 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $240K.
Mangrove Partners first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
Mangrove Partners's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $240K in Q1 2020.
0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Mangrove Partners's 13F filing for Q2 2020, filed 14 Aug 2020.